⌘K
Loading ticker…
As of 2026-08-24, Edgewise Therapeutics, Inc. Common Stock (EWTX) has a 3-month relative strength percentile of 90 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 75. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.4%, relative volume 0.77×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
EWTX is in a stage 2 uptrend, week 11. Currently in a 32-day base; basing ADR 5.5% (broad 5.6%). VCP detected: 3 contractions. RS line below base-start high. Distance from 50d / 200d: 8.5% / 40.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
EWTX is held by 23 ETFs as of May 2026. Top owner: SCHA at 0.05% weight, $12M notional. Top 3 carry $29M.
Held by 53 ETFs · $282M across latest filings · largest weight 2.53% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.05% | $12M | — |
| VTWO | 0.07% | $12M | — |
| VHTVanguard Health Care ETF | 0.03% | $5M | — |
| SBIO | 2.33% | $4M | +0.25 pp |
| VTWG | 0.13% | $2M | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $2M |
| — |
| ESML | 0.05% | $1M | new |
| VFMO | 0.07% | $1M | new |
| ONEQ | 0.01% | $1M | — |
| MMSC | 0.63% | $329K | +0.03 pp |
Showing 10 of 23 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EWTX Jan avg: 23.95% median: 13.93% win: 100% σ: 26.37% n: 4 2022-04-12 → 2026-07-31 | EWTX Feb avg: -3.31% median: -6.48% win: 25% σ: 7.68% n: 4 2022-04-12 → 2026-07-31 | EWTX Mar avg: -7.78% median: -6.23% win: 50% σ: 19.00% n: 4 2022-04-12 → 2026-07-31 | EWTX Apr avg: -0.73% median: -1.71% win: 20% σ: 20.51% n: 5 2022-04-12 → 2026-07-31 | EWTX May avg: -2.68% median: -4.52% win: 40% σ: 15.53% n: 5 2022-04-12 → 2026-07-31 | EWTX Jun avg: 3.96% median: 5.14% win: 60% σ: 20.44% n: 5 2022-04-12 → 2026-07-31 | EWTX Jul avg: 2.69% median: -5.42% win: 40% σ: 12.21% n: 5 2022-04-12 → 2026-07-31 | EWTX Aug avg: 0.18% median: 2.44% win: 75% σ: 10.39% n: 4 2022-04-12 → 2026-07-31 (current) | EWTX Sep avg: 11.17% median: 5.33% win: 50% σ: 22.65% n: 4 2022-04-12 → 2026-07-31 | EWTX Oct avg: 11.70% median: 12.20% win: 75% σ: 11.91% n: 4 2022-04-12 → 2026-07-31 | EWTX Nov avg: 7.47% median: -3.35% win: 25% σ: 23.39% n: 4 2022-04-12 → 2026-07-31 | EWTX Dec avg: 14.01% median: -2.41% win: 25% σ: 44.69% n: 4 2022-04-12 → 2026-07-31 |